Works matching IS 27525481 AND DT 2023 AND VI 19 AND IP 1
Results: 11
Teclistamab Monotherapy for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 46, doi. 10.17925/OHR.2023.19.1.46
- By:
- Publication type:
- Article
Retifanlimab and Other Immune Checkpoint Inhibitors for Squamous Cell Anal Carcinoma.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 41, doi. 10.17925/OHR.2023.19.1.41
- By:
- Publication type:
- Article
Sutimlimab for the Treatment of Cold Agglutinin Disease.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 35, doi. 10.17925/OHR.2023.19.1.35
- By:
- Publication type:
- Article
The Evolving Therapeutic Landscape and Role of Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Systematic Review.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 27, doi. 10.17925/OHR.2023.19.1.27
- By:
- Publication type:
- Article
Durvalumab: A PD-L1 Blocking Antibody for the Treatment of Adult Patients with Locally Advanced or Metastatic Biliary Tract Cancer.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 22, doi. 10.17925/OHR.2023.19.1.22
- By:
- Publication type:
- Article
Nivolumab Combination Therapy for the Treatment of Unresectable Advanced or Metastatic Oesophageal Squamous Cell Carcinoma.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 17, doi. 10.17925/OHR.2023.19.1.17
- By:
- Publication type:
- Article
Tailoring the Treatment of Early-stage HER2-positive Breast Cancer: One Size Does Not Fit All.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 11, doi. 10.17925/OHR.2023.19.1.11
- By:
- Publication type:
- Article
Trastuzumab Deruxtecan for the Treatment of HER2-positive Breast Cancer.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 6, doi. 10.17925/OHR.2023.19.1.6
- By:
- Publication type:
- Article
Pan-RAF Inhibitors for Paediatric Low-grade Gliomas Offer New Opportunities in Targeted Therapy.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 4, doi. 10.17925/OHR.2023.19.1.4
- By:
- Publication type:
- Article
Pafolacianine: A Diagnostic Agent to Identify Lung Cancer Lesions in Adults with Known or Suspected Lung Cancer.
- Published in:
- 2023
- By:
- Publication type:
- Interview
Foreword.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 1
- By:
- Publication type:
- Article